EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Implication of the ADCY1 Gene in Lithium Response in Bipolar Disorder by Genome‐Wide Association Meta‐Analysis

Kai Yao iD, Ayeda Nadeem, Tracey van der Veen, Johan H Thygesen, Lina Jonsson, Jie Song, Mikael Landén iD, Nick Bass, Andrew McQuillin

Bipolar Disorders · 2026-12 · 28 (8)

DOI: 10.1111/bdi.70202 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Bipolar Disorders, online erschienen am 20.11.2026. Verfasst von Kai Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Psychiatry, Molecular Psychiatry Laboratory, University College London, London, UK. Hauptthemen laut MEDLINE: Bipolar Disorder, Adenylyl Cyclases, Lithium Compounds, Antimanic Agents. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Stanley Center for Psychiatric Research at the Broad Institute, NIHR (National Institue for Health Research) funded UCLH (University College London Hospitals NHS Foundation Trust) Biomedical Research Centre (BRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Efforts to examine the influence of genetics in the efficacy of lithium using genome‐wide association studies (GWAS) have identified several loci. Here, we report new cases and meta‐analyses to combine previous efforts.

Methods

We report data from 1259 participants with bipolar disorder (BD) recruited at University College London who had been treated with lithium. The data come from three waves of genotyping on different arrays. The GWAS data from each array was analysed separately and then meta‐analysed with two published lithium response GWAS datasets. Post‐GWAS analyses were conducted to examine lithium response heritability and its genetic correlations with other traits. We also attempted to replicate past polygenic risk scores (PRS) results.

Results

SNP rs116927879 (A/G) was associated with lithium response at a genome‐wide significance level ( p = 4.509 × 10 −08 ) with a consistent effect across all cohorts. rs116927879 is located on chromosome 7 and maps to the protein‐coding gene ADCY1 and two pseudo‐genes, GTF2IP13 and SEPT7P2 . The sQTL results suggested that rs116927879 genotypes may influence the splicing of ADCY1 across different brain regions. We estimated the SNP heritability ( h 2 ) for good lithium response as 20.3% and 15.6% for subjective/objective response definitions, respectively. We did not observe any genetic correlation or PRS association between the lithium response and schizophrenia or major depression disorder. However, we found weak evidence to suggest that males are more likely to be good responders.

Conclusions

Our GWAS identifies a genome‐wide significant finding and provides updated heritability estimates for lithium efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderAdenylyl CyclasesLithium CompoundsAntimanic AgentsHumansGenome-Wide Association StudyPolymorphism, Single NucleotideMaleFemaleGenetic Risk Score

Stichwörter der Autor:innen

bipolar disordergenome‐wide association studiesheterogeneitylithiummeta‐analysis

Substanzen

Adenylyl CyclasesLithium CompoundsAntimanic Agentsadenylyl cyclase type V

Autor:innen und Institutionen

  • Division of Psychiatry, Molecular Psychiatry Laboratory, University College London, London, UK.
  • Institute of Health Informatics, University College London, London, UK.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Mental Health Center and West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Kai Yao, Mikael Landén

Förderung

  • Medical Research Council
  • Stanley Center for Psychiatric Research at the Broad Institute
  • NIHR (National Institue for Health Research) funded UCLH (University College London Hospitals NHS Foundation Trust) Biomedical Research Centre (BRC)
  • Stanley Center for Psychiatric Research, Broad Institute

Zitieren

APA

Yao, K., Nadeem, A., van der Veen, T., Thygesen, J. H., Jonsson, L., Song, J., Landén, M., Bass, N., & McQuillin, A. (2026). Implication of the ADCY1 Gene in Lithium Response in Bipolar Disorder by Genome‐Wide Association Meta‐Analysis. Bipolar Disorders, 28(8). https://doi.org/10.1111/bdi.70202

Vancouver

Yao K, Nadeem A, van der Veen T, Thygesen JH, Jonsson L, Song J, et al. Implication of the ADCY1 Gene in Lithium Response in Bipolar Disorder by Genome‐Wide Association Meta‐Analysis. Bipolar Disorders. 2026;28(8). doi:10.1111/bdi.70202

BibTeX
@article{Yao2026,
  author = {Yao, Kai and Nadeem, Ayeda and van der Veen, Tracey and Thygesen, Johan H and Jonsson, Lina and Song, Jie and Landén, Mikael and Bass, Nick and McQuillin, Andrew},
  title = {Implication of the ADCY1 Gene in Lithium Response in Bipolar Disorder by Genome‐Wide Association Meta‐Analysis},
  journal = {Bipolar Disorders},
  year = {2026},
  volume = {28},
  number = {8},
  doi = {10.1111/bdi.70202}
}
Kostenlos starten →